Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
TUBULAR HEMORRHOID STAPLER MARKET
The global tubular hemorrhoid stapler market was valued at approximately USD 312 million in 2024. The market is projected to grow from USD 332 million in 2025 to reach USD 472 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% during the forecast period. This growth is embedded within the broader medical devices market, which was estimated at USD 603 billion in 2023 and is itself growing at a steady rate.
A tubular hemorrhoid stapler, also known as a circular stapler or Procedure for Prolapse and Hemorrhoids (PPH) stapler, is a specialized surgical instrument used primarily for the treatment of internal hemorrhoids. This device is designed to excise a circumferential ring of prolapsed hemorrhoidal tissue and simultaneously fire a circular ring of staples to reposition the remaining tissue and restore normal anatomy, a technique that typically results in less postoperative pain and a quicker recovery compared to traditional hemorrhoidectomy.
The market is driven by several key factors, including the rising global prevalence of hemorrhoidal disease, which affects a significant portion of the adult population. Furthermore, the increasing preference for minimally invasive surgical procedures and the growing adoption of advanced surgical techniques in both hospitals and day surgery centers are significant contributors to market expansion. While the market is growing, it faces challenges such as the high cost of devices and potential postoperative complications. Leading players in this space, including Touchstone, Medtronic (through brands like Stapleline), and a number of prominent Chinese manufacturers like Jiangsu Qianjing Medical Equipment, are focused on technological innovations to enhance the safety and efficacy of these devices.
Rising Prevalence of Hemorrhoidal Disease
The global increase in sedentary lifestyles, low-fiber diets, and rising obesity rates contributes significantly to the growing incidence of hemorrhoidal disease. This creates a consistent and expanding patient pool requiring medical intervention. The aging global population, which is more susceptible to this condition, further fuels the demand for effective treatment options, thereby driving the market for tubular hemorrhoid staplers, which are widely used in procedures like the Procedure for Prolapse and Hemorrhoids (PPH).
Advantages Over Conventional Hemorrhoidectomy
Tubular hemorrhoid staplers are favored for the PPH technique, which offers substantial clinical benefits compared to traditional excisional hemorrhoidectomy. These key advantages include reduced postoperative pain, shorter operating times, and a quicker return to normal activities for patients. The minimally invasive nature of the procedure, which resects a ring of prolapsed tissue while restoring anatomy, leads to higher patient satisfaction and is a primary driver for the adoption of these specialized staplers.
A recent multi-center study indicated that PPH procedures using tubular staplers resulted in a 50% reduction in postoperative pain scores compared to traditional surgery.
The increasing number of ambulatory surgical centers (ASCs) also propels market growth. These facilities prioritize efficient, outpatient procedures with rapid patient turnover, making PPH with tubular staplers an ideal option, thereby increasing the volume of procedures performed and the demand for the devices.
MARKET CHALLENGES
High Cost of Procedure and Devices
The significant cost of disposable tubular hemorrhoid staplers represents a major challenge, especially in cost-sensitive markets and healthcare systems with budget constraints. A single-use stapler represents a considerable per-procedure expense, which can limit its adoption in public healthcare systems and regions with lower reimbursement rates, where clinicians may opt for more affordable, albeit less advanced, surgical techniques.
Other Challenges
Risk of Postoperative Complications
While generally safe, procedures using tubular hemorrhoid staplers are associated with specific, albeit rare, complications such as persistent pain, bleeding, stenosis, or rectal wall perforation. These risks necessitate high surgical skill and can lead to product liability concerns and a degree of caution among some surgeons, potentially restraining market growth.
Procedure-Specific Limitations
The PPH technique is primarily indicated for internal hemorrhoidal prolapse (Grades III and IV) and is not suitable for all types of hemorrhoids, such as isolated external components. This limitation on the addressable patient population can restrict the overall volume of procedures performed with these devices compared to more universally applicable surgical methods.
Availability of Alternative Treatment Modalities
The market for tubular hemorrhoid staplers faces competition from a range of less invasive and non-surgical treatments. Techniques such as rubber band ligation, sclerotherapy, and infrared coagulation are effective for lower-grade hemorrhoids and are often performed in an office setting at a fraction of the cost of a surgical procedure. Furthermore, advanced energy-based devices for hemorrhoidectomy, including LigaSure and harmonic scalpels, offer surgical alternatives that compete directly with stapled hemorrhoidopexy, restraining the market's potential.
Stringent Regulatory Hurdles
As Class II medical devices, tubular hemorrhoid staplers are subject to rigorous regulatory scrutiny by bodies like the US FDA and the European CE marking process. The lengthy and costly process of obtaining and maintaining regulatory approvals for new devices or significant design changes can delay market entry and innovation, acting as a significant barrier for manufacturers and limiting the pace of market expansion.
Expansion in Emerging Economies
Rapidly developing healthcare infrastructure, growing medical tourism, and an increasing middle-class population in regions such as Asia-Pacific and Latin America present a significant growth opportunity. As access to advanced surgical care improves in these countries, the demand for minimally invasive procedures like stapled hemorrhoidopexy is expected to rise substantially, offering manufacturers new and expanding markets for their products.
Technological Advancements
There is considerable opportunity for innovation in tubular hemorrhoid stapler design. The development of next-generation devices featuring enhanced ergonomics, improved safety mechanisms to minimize complications like anastomotic leakage, and the integration of bioabsorbable stapler lines could significantly improve clinical outcomes and drive market differentiation and growth. Such advancements would address current limitations and strengthen the value proposition of the stapled technique.
Rising Surgeon Training and Awareness
Increased efforts by leading manufacturers and surgical associations to provide specialized training programs and workshops on the PPH technique can expand the pool of qualified surgeons. As more surgeons become proficient and confident in using tubular hemorrhoid staplers, procedural adoption rates are likely to increase, particularly in community hospital settings, unlocking further market potential.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Disposable staplers are the dominant segment, primarily driven by stringent hospital policies concerning infection control and cross-contamination prevention. The single-use nature eliminates the need for complex and costly reprocessing procedures, ensuring consistent sterility and operational reliability for every procedure. This segment's growth is further supported by the increasing emphasis on patient safety standards globally and the operational efficiencies they offer to healthcare facilities by reducing sterilization workload and potential liabilities associated with reusable instrument failure. |
| By Application |
|
Hospitals represent the leading application segment for tubular hemorrhoid staplers, as they are the primary centers for performing complex surgical procedures like stapled hemorrhoidopexy. Their dominance is underpinned by the availability of specialized surgical units, trained colorectal surgeons, and the necessary infrastructure for inpatient care. The segment benefits from high patient volume and the ability to handle cases with potential complications. Meanwhile, Day Surgery Centers are experiencing growth due to the trend towards outpatient procedures, offering cost-effectiveness and convenience for eligible patients, though they are typically limited to less complex cases. |
| By End User |
|
Public Healthcare Institutions constitute a major end-user segment due to their vast patient catchment areas and government funding for surgical treatments. These institutions often have standardized procurement processes favoring cost-effective and reliable medical devices for high-volume use. Conversely, Private Clinics & Hospitals are significant drivers of premium and advanced stapler adoption, focusing on patient comfort, shorter recovery times, and cutting-edge technology to differentiate their services. Ambulatory Surgical Centers are a growing end-user channel, aligning with the shift towards minimally invasive surgeries that allow for same-day discharge. |
| By Stapler Diameter |
|
Standard Diameter staplers are the most widely used segment, designed to accommodate the anatomical requirements of a broad patient population for common hemorrhoid cases. Their versatility and suitability for a wide range of procedures make them the workhorse instruments in this market. Large and Extra-Large Diameter staplers cater to specific clinical needs, such as treating more advanced prolapse or patients with unique anatomies. The availability of multiple sizes is critical for surgical precision and patient outcomes, driving the need for comprehensive product portfolios from manufacturers. |
| By Technology |
|
Manual/Mechanical staplers currently lead the market, valued for their simplicity, reliability, and lower cost. Surgeons are highly familiar with their operation, which involves direct mechanical action to deploy the staples. However, the segment for Powered staplers is an area of innovation and growth. These devices offer potential benefits such as more consistent staple formation, reduced surgeon fatigue during prolonged procedures, and integration with advanced features that may improve procedural accuracy. Adoption is gradual, influenced by factors like cost, training requirements, and demonstrating clear clinical advantages over established manual techniques. |
A Market Characterized by Specialized Medical Device Manufacturers
The global tubular hemorrhoid stapler market features a competitive environment with a mix of established medical device companies and specialized manufacturers. Market leadership is often associated with companies that have strong surgical instrument portfolios and extensive distribution networks for hospital and surgical center channels. Product innovation, particularly in developing reliable and easy-to-use disposable staplers, is a key competitive factor. Manufacturers compete on product quality, pricing, regulatory approvals, and clinical support services provided to surgeons.
The market also includes several significant niche players, often based in regions with strong medical device manufacturing capabilities like China and other parts of Asia. These companies frequently compete by offering cost-effective alternatives and focusing on specific geographic markets. The competitive dynamics are further influenced by the critical nature of the product, requiring adherence to stringent quality standards and regulatory clearances from bodies like the FDA and CE marking in Europe, which creates barriers to entry and consolidates market share among compliant manufacturers.
List of Key Tubular Hemorrhoid Stapler Companies ProfiledTouchstone
WASTON
Surgaid Medical
Atlas Medical
PT. Hospi Medik Indonesia
Tiansong Medical Instrument
Geyi Medical Instrument
Jiangsu Ruipu Medical Device Technology
The global tubular hemorrhoid stapler market is characterized by an increasing preference for minimally invasive surgical options. The procedure for prolapse and hemorrhoids (PPH), performed with a circular stapler, is a key driver of market growth. This technique is associated with reduced postoperative pain, shorter hospital stays, and faster patient recovery times compared to traditional hemorrhoidectomy. As patient awareness and demand for less invasive treatments rise, the adoption of tubular hemorrhoid staplers is expanding. This trend is supported by continuous advancements in medical technology, leading to the development of more precise and user-friendly stapling devices.
Other TrendsDominance of Disposable Products
A significant trend within the market is the shift towards disposable tubular hemorrhoid staplers over reusable models. Disposable staplers eliminate the risk of cross-contamination and the need for costly and labor-intensive sterilization processes. For healthcare providers, this translates into enhanced operational efficiency and improved patient safety protocols. Consequently, manufacturers are increasingly focusing their development and production efforts on single-use devices, which now command a larger segment of the market share.
Expansion in Hospital and Ambulatory Surgery Settings
The application of tubular hemorrhoid staplers is primarily concentrated in hospitals, which remain the largest end-user segment. However, there is a notable and accelerating trend of adoption in day surgery centers. The efficiency and rapid patient turnover associated with the PPH procedure make it particularly well-suited for ambulatory settings. This shift is part of a broader movement in healthcare to perform more procedures in outpatient facilities to reduce overall treatment costs and improve accessibility for patients.
Regional Market Growth DynamicsGeographically, the market growth is robust in the Asia-Pacific region, driven by factors such as rising healthcare expenditure, growing medical tourism, and improving healthcare infrastructure. Countries like China, India, and Japan are seeing increased adoption of advanced surgical techniques. Meanwhile, North America and Europe continue to represent mature yet steady markets, sustained by high procedural volumes, well-established healthcare systems, and the presence of leading medical device manufacturers. The global market is projected to reach a valuation of millions of US dollars by 2032, reflecting a compound annual growth rate fueled by these underlying trends.
Regional Analysis: Tubular Hemorrhoid Stapler MarketEurope
Europe represents a mature and significant market for tubular hemorrhoid staplers, characterized by established healthcare systems and a high standard of surgical care. Countries such as Germany, France, and the United Kingdom are major contributors, with well-defined clinical guidelines that often recommend stapled hemorrhoidopexy for appropriate cases. The market growth is supported by an aging population, which is more susceptible to hemorrhoidal disease, and a strong emphasis on minimally invasive surgical training within the medical community. However, the market dynamics can vary between Western and Eastern Europe due to differences in healthcare spending and infrastructure. Price sensitivity and stringent regulatory processes through bodies like the CE mark influence product availability and adoption rates. The region also shows a trend towards ambulatory surgery centers, which favor procedures utilizing staplers due to their efficiency and shorter operation times.
Asia-Pacific
The Asia-Pacific region is identified as the fastest-growing market for tubular hemorrhoid staplers, driven by improving healthcare infrastructure, rising medical tourism, and increasing healthcare expenditure. Countries like China, Japan, and India are witnessing a surge in demand, fueled by a growing awareness of advanced treatment options and a rising prevalence of anorectal disorders. The large population base presents a substantial addressable market. However, market penetration is uneven, with major urban centers adopting advanced technologies much faster than rural areas. The cost of devices remains a consideration, but local manufacturing in some countries is helping to improve affordability. Medical professionals are increasingly being trained in modern surgical techniques, which is crucial for the adoption of stapler procedures.
South America
The South American market for tubular hemorrhoid staplers is in a developing phase, with growth potential tied to economic stability and healthcare modernization. Brazil and Argentina are the key markets, where private healthcare sectors are more proactive in adopting new technologies. Public healthcare systems face budgetary constraints, which can limit the widespread availability of advanced surgical devices. The region sees a gradual increase in the number of trained surgeons proficient in stapling techniques. Cultural factors and patient awareness are also evolving, leading to a slow but steady increase in the acceptance of minimally invasive procedures for hemorrhoid treatment.
Middle East & Africa
The Middle East and Africa region presents a varied landscape for the tubular hemorrhoid stapler market. The Gulf Cooperation Council (GCC) countries, with their high per capita healthcare spending and advanced medical facilities, form the core of the market. These nations attract medical tourists and have surgeons well-versed in the latest techniques. In contrast, many parts of Africa face significant challenges, including limited access to advanced medical devices, a shortage of specialized surgeons, and constrained healthcare budgets. The overall market growth is nascent but shows promise, particularly in urban centers where healthcare infrastructure is being upgraded and specialist training programs are being introduced.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Medical device manufacturers
Healthcare providers and hospital systems
Surgical equipment suppliers
Investors, consultants, and policy makers
Research organizations and academic institutions
-> Global tubular hemorrhoid stapler market was valued at USD 312 million in 2024 and is expected to reach USD 472 million by 2032.
-> Key players include Touchstone, Stapleline, WASTON, Surgaid Medical, and Jiangsu Qianjing Medical Equipment, among others.
-> Key growth drivers include rising prevalence of hemorrhoidal disease, preference for minimally invasive procedures, and adoption of advanced surgical techniques.
-> Asia shows significant growth potential, while Europe and North America maintain strong market positions.
-> Emerging trends include technological innovations for enhanced safety, disposable device options, and expanding applications in day surgery centers.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates